I guess I don't understand. How is this OTC EPA getting the pure EPA if generic DRL is taking Amarin to court because there is limited supply due to Amarin and their contracts for supply? Also, Hikma is having a hard time with supply so how is the over the counter company's getting pure EPA?
Market Data 
Markets 
AI
